The applicants propose development of an efficient hybridization screening test for mutations in the lacI gene based on a microwell transfer pin approach and a """"""""probe"""""""" pooling strategy. The goal is to provide """"""""mutational fingerprints or spectra"""""""" capable of defining levels and mechanism of mutation induced by individual mutagenic compounds. The test will use Stratagene's BigBlue transgenic system to recover mutants. However, the present proposal seeks to develop a strategy whereby fluorescein- labeled oligonucleotides probes complementary to selected lacI mutations are specifically annealed to biotin-labeled PCR products immobilized on streptavidin-coated pins. Positive hybridization events are revealed by a colorimetric reaction using anti-fluorescein-horse radish peroxidase conjugates in microwells.

Proposed Commercial Applications

Not available

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA081582-01
Application #
2852955
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (02))
Program Officer
Miller, William C
Project Start
1999-02-08
Project End
1999-08-07
Budget Start
1999-02-08
Budget End
1999-08-07
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Saigene Corporation
Department
Type
DUNS #
City
Redmond
State
WA
Country
United States
Zip Code
98052